BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 29145975)

  • 1. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-to-I RNA editing - thinking beyond the single nucleotide.
    Ganem NS; Lamm AT
    RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA editing by mammalian ADARs.
    Hogg M; Paro S; Keegan LP; O'Connell MA
    Adv Genet; 2011; 73():87-120. PubMed ID: 21310295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All I's on the RADAR: role of ADAR in gene regulation.
    Shevchenko G; Morris KV
    FEBS Lett; 2018 Sep; 592(17):2860-2873. PubMed ID: 29770436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of widespread ultra-edited human RNAs.
    Carmi S; Borukhov I; Levanon EY
    PLoS Genet; 2011 Oct; 7(10):e1002317. PubMed ID: 22028664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins.
    Mannion N; Arieti F; Gallo A; Keegan LP; O'Connell MA
    Biomolecules; 2015 Sep; 5(4):2338-62. PubMed ID: 26437436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editor meets silencer: crosstalk between RNA editing and RNA interference.
    Nishikura K
    Nat Rev Mol Cell Biol; 2006 Dec; 7(12):919-31. PubMed ID: 17139332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-to-I RNA editing and cancer: from pathology to basic science.
    Gallo A; Galardi S
    RNA Biol; 2008; 5(3):135-9. PubMed ID: 18758244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To edit or not to edit: regulation of ADAR editing specificity and efficiency.
    Deffit SN; Hundley HA
    Wiley Interdiscip Rev RNA; 2016; 7(1):113-27. PubMed ID: 26612708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR).
    Solomon O; Oren S; Safran M; Deshet-Unger N; Akiva P; Jacob-Hirsch J; Cesarkas K; Kabesa R; Amariglio N; Unger R; Rechavi G; Eyal E
    RNA; 2013 May; 19(5):591-604. PubMed ID: 23474544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing.
    Osenberg S; Paz Yaacov N; Safran M; Moshkovitz S; Shtrichman R; Sherf O; Jacob-Hirsch J; Keshet G; Amariglio N; Itskovitz-Eldor J; Rechavi G
    PLoS One; 2010 Jun; 5(6):e11173. PubMed ID: 20574523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine-to-inosine RNA editing meets cancer.
    Dominissini D; Moshitch-Moshkovitz S; Amariglio N; Rechavi G
    Carcinogenesis; 2011 Nov; 32(11):1569-77. PubMed ID: 21715563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey on cellular RNA editing activity in response to Candida albicans infections.
    Huang Y; Cao Y; Li J; Liu Y; Zhong W; Li X; Chen C; Hao P
    BMC Genomics; 2018 Jan; 19(Suppl 1):43. PubMed ID: 29363428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
    Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
    Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAR RNA editing below the backbone.
    Keegan L; Khan A; Vukic D; O'Connell M
    RNA; 2017 Sep; 23(9):1317-1328. PubMed ID: 28559490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome.
    Aktaş T; Avşar Ilık İ; Maticzka D; Bhardwaj V; Pessoa Rodrigues C; Mittler G; Manke T; Backofen R; Akhtar A
    Nature; 2017 Apr; 544(7648):115-119. PubMed ID: 28355180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-to-I editing of coding and non-coding RNAs by ADARs.
    Nishikura K
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.